Everest Group assessed YPrime's eCOA platform, which serves pharmaceutical companies for clinical trials.
1 report, 1 independent
Updated Sep 3
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Everest Group assessed YPrime's eCOA platform, which serves pharmaceutical companies for clinical trials.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Everest
British company that manufactures and installs double glazing & triple glazing windows and doors, focusing on energy efficient homes.
Coverage
Newest first; wire copies grouped- GlobeNewswireYPrime Named a Leader in Everest Group’s 2025 eCOA PEAK Matrix® Assessment Recognition highlights the strength of YPrime’s eCOA platform in delivering faster, more flexible global trials with high-qu